Table I.
Association between microRNA-124 expression and clinicopathologic characteristics of bladder cancer patients.
| Variable | Total (n=73) | Low expression (n=38) | High expression (n=35) | P-value |
|---|---|---|---|---|
| Sex | 0.214 | |||
| Male | 51 | 24 | 27 | |
| Female | 22 | 14 | 8 | |
| Age (years) | 0.294 | |||
| ≤60 | 53 | 30 | 23 | |
| >60 | 20 | 8 | 12 | |
| Tumor size (cm) | 0.162 | |||
| ≤3 | 37 | 16 | 21 | |
| >3 | 36 | 22 | 14 | |
| Grade | 0.182 | |||
| Well and moderately differentiated | 55 | 26 | 29 | |
| Poorly differentiated | 18 | 12 | 6 | |
| Clinical T stage | 0.005 | |||
| Ta+Tis+T1 | 31 | 10 | 21 | |
| T2-T4 | 42 | 28 | 14 | |
| Lymph node metastasis | 0.025 | |||
| Present | 25 | 18 | 7 | |
| Absent | 48 | 20 | 28 | |
| Distant metastasis | 0.109 | |||
| Present | 7 | 6 | 1 | |
| Absent | 66 | 32 | 34 |